Ramos Cells

The Ramos cell line, established from the ascites fluid of a 3-year-old boy with Burkitt's Lymphoma, is a crucial resource in immunology research. This cell line, characterized by the secretion of IgM, is invaluable for the analysis of B cell surface antigens, cytotoxic drug testing, mutational analysis, and the exploration of apoptotic mechanisms. RAMOS cells exhibit a lymphoblast-like morphology and are known for their robust growth in vitro. They are particularly valuable in studies related to B-cell development, function, and malignancy, including the investigation of B-cell receptor (BCR) signaling pathways, gene expression, and the mechanisms underlying the transformation of normal B cells into malignant cells. These cells are also frequently used in antibody production studies due to their B-cell lineage, allowing researchers to explore B-cell responses to various antigens and the subsequent antibody generation. RAMOS cells are further utilized in drug discovery and toxicity studies. Their sensitivity to various chemotherapeutic agents make them an invaluable tool in the pre-clinical evaluation of new cancer therapies. Notably, the Ramos cell line is EBV-negative, providing a baseline model for studying Burkitt lymphoma without the influence of the Epstein-Barr virus. In summary, the Ramos cell line is an invaluable asset in the study of B-cell biology and Burkitt's lymphoma and are instrumental in exploring B-cell development, malignancy, antibody production, and the efficacy of new cancer therapies. Burkitt Lymphoma cell lines, Hematopoietic, Burkitt lymphoma, Growth Conditions: Suspension, Biosafety level: BSL 1